Cosa vuol dire EBV VCA e perché riguarda la mononucleosi
Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model - ScienceDirect
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis | Science
VIDAS EBV panel, diagnosis of Mononucleosis | bioMérieux Clinical Diagnostics
Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD/Shi-scid/IL-2Rγnull mice | PLOS ONE
Epstein‐Barr virus strain variation and cancer - Kanda - 2019 - Cancer Science - Wiley Online Library
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
Molecules | Free Full-Text | Novel Therapeutics for Epstein–Barr Virus | HTML
Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases | Journal of Virology
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
Detection of Epstein-Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay
EBV EBNA-1 Antibody (1EB12) | SCBT - Santa Cruz Biotechnology
Frontiers | Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus Infections | NEJM
Frontiers | Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis
BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells | Science Advances
Anticorpi anti virus Epstein-Barr (EBV) - Analisi Papagni
Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Antagonizing EphA2 ectodomain function markedly impairs EBV infection... | Download Scientific Diagram
Vaccination against the Epstein–Barr virus | SpringerLink
Elecsys® EBV panel
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM | Nature
IJMS | Free Full-Text | New Viral Facets in Oral Diseases: The EBV Paradox | HTML
Clinical effects of infusing anti-epstein-barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic ac
